Real-life experience with pirfenidone in idiopathic pulmonary fibrosis (IPF) in a single centre in Italy. A retrospective study

被引：0
|
作者：
Tavanti, Laura
De Magistris, Sara
Romei, Chiara
Perrone, Elisabetta
Falaschi, Fabio
Nieri, Dario
Serradori, Massimiliano
Celi, Alessandro
Palla, Antonio
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.PA3825
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3825
引用
收藏
页数：1
相关论文
共 50 条
  • [21] SINGLE CENTRE EXPERIENCE OF SWITCHING PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS FROM PIRFENIDONE TO NINTEDANIB
    Rathnapala, A.
    Fries, A.
    Ruggiero, C.
    Ho, L. P.
    Hoyles, R. K.
    [J]. THORAX, 2016, 71 : A60 - A60
  • [22] Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-Life Experience from a German Tertiary Referral Center for Interstitial Lung Diseases
    Oltmanns, Ute
    Kahn, Nicolas
    Palmowski, Karin
    Traeger, Annette
    Wenz, Heinrich
    Heussel, Claus Peter
    Schnabel, Philipp A.
    Puderbach, Michael
    Wiebel, Matthias
    Ehlers-Tenenbaum, Svenja
    Warth, Arne
    Herth, Felix J. F.
    Kreuter, Michael
    [J]. RESPIRATION, 2014, 88 (03) : 199 - 207
  • [23] Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases
    Oltmanns, Ute
    Kahn, Nicolas
    Wenz, Heinrich
    Heussel, Claus-Peter
    Puderbach, Michael
    Ehlers-Tenenbaum, Svenja
    Warth, Arne
    Herth, Felix
    Schnabel, Philip
    Kreuter, Michael
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [24] Pirfenidone and Nintedanib Therapy for Idiopathic Pulmonary Fibrosis: A Tertiary Centre Experience
    Diab, N.
    Mao, T.
    Danoff, S. K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [25] Pirfenidone improves survival in IPF: results from a real-life study
    Margaritopoulos, George A.
    Trachalaki, Athina
    Wells, Athol U.
    Vasarmidi, Eirini
    Bibaki, Eleni
    Papastratigakis, George
    Detorakis, Stathis
    Tzanakis, Nikos
    Antoniou, Katerina M.
    [J]. BMC PULMONARY MEDICINE, 2018, 18
  • [26] Prescription Of Pirfenidone And Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis (ipf): An Academic Center Experience
    Strock, S.
    Nouraie, S. M.
    Huttenhower, D.
    Chen, X.
    Lawson, K.
    Priore, M. Melissa
    Chiarchiaro, J.
    Veraldi, K. L.
    Lindell, K. O.
    Gibson, K. F.
    Kass, D. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] Pirfenidone improves survival in IPF: results from a real-life study
    George A. Margaritopoulos
    Athina Trachalaki
    Athol U. Wells
    Eirini Vasarmidi
    Eleni Bibaki
    George Papastratigakis
    Stathis Detorakis
    Nikos Tzanakis
    Katerina M. Antoniou
    [J]. BMC Pulmonary Medicine, 18
  • [28] Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
    Leceuvre, Katleen
    De Dycker, Els
    Moerman, Tom
    Yserbyt, Jonas
    Wuyts, Wim
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [29] Single Center Experience with Pirfenidone in Management of Idiopathic Pulmonary Fibrosis: Retrospective Observational Study of Pirfenidone Therapeutic Effect and Side Effect Profile
    Elshafi, M.
    Murphy, L.
    O'Connell, O.
    Riddel, P.
    Barry, P. J.
    Egan, J. J.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S434 - S435
  • [30] Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study
    Furuya, Kenta
    Sakamoto, Susumu
    Shimizu, Hiroshige
    Sekiya, Muneyuki
    Kinoshita, Arisa
    Isshiki, Takuma
    Sugino, Keishi
    Matsumoto, Keiko
    Homma, Sakae
    [J]. RESPIRATORY MEDICINE, 2017, 126 : 93 - 99
12345